Recent studies have reported that endogenous proteases, including CD10, MMP9, cathepsin D, and cathepsin B, showed fibrinolytic capacity to amyloid-beta fibrils of Alzheimer's disease [15, 16]. This evidence concerns the gene MMP9 and early-onset autosomal dominant Alzheimer disease.